Font Size: a A A

Tailixin Capsule For Angina Pectoris Of Coranary Heart Disease (heart Blood Stasis Syndrome): Phase â…¡ Multi-central Clinical Trials

Posted on:2011-09-18Degree:MasterType:Thesis
Country:ChinaCandidate:J LiFull Text:PDF
GTID:2194330332984750Subject:Traditional Chinese Medicine
Abstract/Summary:PDF Full Text Request
Objective:To observe the clinical efficacy and security of TaiLiXin capsule in treating Coronary heart disease angina (heart blood stasis syndrome).Methods:90 cases of CHD angina with heart blood stasis syndrome, aged 40 to 70,were enrolled from out-patient department of Chengdu University of TCM and another test center with randomization,double blindness and multi-central method required in the phaseâ…¡clinical trials.They were randomly divided into three groups. A group takes low doses of TaiLiXin capsule including 30 cases. B group takes placebo including 30 cases. C group takes high doses of TaiLiXin capsule including 30 cases.The period of treatment is 4 weeks.After 4 weeks,observe the curative effect of Angina symptoms,of electrocardiogram, of the athletic flat, of the rate of suspending from nitroglycerin.Results:1. Curative effect evaluation:(1) Angina pectoris curative effect evaluation:The total efficiency rate is 82.76% and the show efficiency is 37.93% in C group.The two indexes are respectively 58.63% and 27.59% in A group,43.33% and 16.67% in B group. There are significant differences in three groups by statistical disposal.(2)Electrocardiogram curative effect evaluation:The total efficiency rate is 68.97% and the show efficiency is 27.59% in C group.The two indexes are respectively 55.27% and 20.69% in A group,33.67% and 6.67% in B group. There are significant differences in three groups by statistical disposal.(3)Blood stasis resistance effect evaluation:The total efficiency rate is 79.31% and the show efficiency is 37.97% in C group.The two indexes are respectively 58.62% and 20.69% in A group,46.67% and 13.33% in B group. There are significant differences in three groups by statistical disposal.(4)The rate of suspending from nitroglycerin curative effect evaluation:The rate of suspending from nitroglycerin is 77.27% in C groups 50% in A group and 34.78% in B group.There are significant differences in three groups by statistical disposal. 2.During the whole course of the test, the bad affair never happened. The medicine has good security.Conclusion:TaiLiXin capsule has remarkable effects on the symptoms of Angina Pectoris and TCM syndromes of the patients with angina Pectoris(belonged to the heart blood stasis syndrome).It can improve electrocardiogram ischemia.It also has remarkable effects on the ceasing and decreasing rate of Glonoin of the patients with angina Pectoris. TaiLiXin capsule has good security.
Keywords/Search Tags:Coronary heart diseaseangina pectoris, heart blood stasis syndrome, TaiLiXin capsule, clinical trial
PDF Full Text Request
Related items
Tailixin Capsule For Angina Pectoris Of Coranary Heart Disease (heart Blood Stasis Syndrome): Phase â…¡ Multi-central Clinical Trials
Tailixin Capsule For Heart Blood Stasis Syndrome Of Chest Bi (angina Pectoris Of Coranary Heart Disease): A Randomized Double-blind Controlled Clinical Trial
Tailixin Capsule For Heart Blood Stasis Syndrome Of Chest Bi (Angina Pectoris Of Coranary Heart Disease): A Randomized Double-blind Controlled Clinical Trial
A Clinical Trial To Evaluate The Effect Of Safflower Yellow Injection In Treating Coronary Heart Disease Angina Pectoris(Heart Blood Stasis Syndrome)
The Clinical Observation Of Tianxiangdan Capsule In Treating Angina Pectoris In Coronary Heart Disease(Syndrome Of Qi Deficiency And Blood Stasis)
Effect Of Xinyi Capsule In People With Stable Angina Pectoris (Qi-Deficiency And Blood-Stasis Syndrome): A Randomized, Double-Blind Lacebo-Controlled Four Weeks Trial
Tongmai Yixin Capsule Treatment Of Angina Pectoris (heart Blood Stasis Syndrome) Clinical Observation
Safflower Yellow Injection In The Treatment Of Angina Pectoris (heart Blood Stasis Syndrome) Clinical Studies
Coronary Heart Disease Syndromes Distribution Characteristics Of Cross-sectional And Traditional Chinese Medicine The Treatment Of Coronary Heart Disease (Blood Stasis Syndrome) Clinical Study
10 Clinical And Mechanism Research Of Xuefu Zhuyu Capsule In The Treatment Of Qi Stagnation And Blood Stasis Syndrome Of Coronary Heart Disease With Angina Pectoris Based On Transcriptomics